National Summary Report
Latest data from June 2, 2023
HRSA uses the information collected to: optimize COVID-19 testing and vaccination; track health center capacity and the impact of COVID-19 on operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.
Health Center COVID-19 Survey Tool Questions
Health Center COVID-19 Survey Tool User Guide
Health Center Program Look-Alike Survey Data for COVID-19
COVID-19 Health Center Survey Interactive Data Dashboards
View cumulative vaccination data nationally; by state, territory, and freely associated state; and among patients identified as racial and/or ethnic minorities. New data views: total vaccinations (all sources) and Health Center Vaccine Program (federal allocations only).
View COVID-19 testing data by race/ethnicity.
Note: The dashboard data are updated bi-weekly using Health Center COVID-19 Survey data.
Number of Health Center respondents = 1020 (75% of all Health Centers)
Data represents information provided by health centers funded through H80 grants from a single, specified bi-weekly reporting date as indicated above. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 52,668 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) |
67.44%
|
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 3,828 |
| Racial and/or Ethnic Minority Patients | 72.75% |
Patients Tested by Race and Ethnicity
| Race/Ethnicity | Patients Tested by race and ethnicity, Virus Detection (PCR, antigen)2 | Patients Tested Positive by race and ethnicity, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 30.02% | 25.57% |
| White, Hispanic/Latino Patients | 29.56% | 34.56% |
| Black/African American, Non-Hispanic/Latino Patients |
11.44% |
8.41% |
| Black/African American, Hispanic/Latino Patients | 1.14% | 1.80% |
| Asian Patients3 | 2.46% | 4.44% |
| American Indian/Alaska Native Patients3 |
2.01% |
1.67% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.09% | 0.60% |
| Patients with More Than One Race3 | 5.26% | 9.72% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 9.24% | 7.08% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.05% | 1.49% |
| Unreported/Refused to Report Race and Ethnicity | 5.74% | 4.65% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 4,272 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 78.19% |
| COVID-19 Immunization Series Completed | 2,584 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 77.52% |
| COVID-19 Immunization Series Additional | 15,304 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 70.82% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 19.34% | 20.12% | 26.60% |
| White, Hispanic/Latino Patients | 29.49% | 28.25% | 24.46% |
| Black/African American, Non-Hispanic/Latino Patients | 13.65% |
14.94% |
11.95% |
| Black/African American, Hispanic/Latino Patients | 1.22% | 0.89% | 0.74% |
| Asian Patients3 | 5.13% |
6.11% |
9.59% |
| American Indian/Alaska Native Patients3 | 0.98% | 0.74% | 2.71% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.43% | 1.12% | 1.06% |
| Patients with More Than One Race3 | 3.93% | 4.61% | 4.08% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 13.48% | 12.73% | 9.97% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 3.49% | 3.06% | 2.03% |
| Unreported/Refused to Report Race and Ethnicity |
7.87% |
7.43% | 6.80% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 30.88% |
| 1 to 24 Hours | 35.29% |
| More Than 24 Hours | 28.73% |
| N/A | 5.10% |
Operations and Staff
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Community-Based Events (Mobile Vans, Pop-Up Clinics, School-Based Sites, or Family Vaccination Clinics) | 20.20% |
| Number of Community-Based Events | 1,131 |
| Number of Collaboration Community-Based Events | 397 |
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 27.84% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 38.14% |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 133,841 |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask | 12.55% |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 22,412
|
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 14.80%
|
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 | 69.25% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 24.93% |
| White, Hispanic/Latino Patients | 33.80% |
| Black/African American, Non-Hispanic/Latino Patients | 7.76% |
| Black/African American, Hispanic/Latino Patients | 0.55% |
| Asian Patients3 | 12.19% |
| American Indian/Alaska Native Patients3 | 0.97% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.25% |
| Patients with More Than One Race3 | 5.68% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 7.06% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
1.66% |
| Unreported/Refused to Report Race and Ethnicity | 4.16% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 5.26% |
| Patients Experiencing Homelessness | 1.25% |
| Patients Who Are Residents of Public Housing | 7.06% |
| Patients with Limited English Proficiency |
28.53% |
| Children Under 18 Years of Age | 0.97% |
Results from States and Territories
Select a measure on the dropdown menu to view by state or territory.
1 The reported number of patients tested does not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.